Chong Kun Dang Pharmaceutical Corp. (185750.KS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap1.05T
EV1.05T
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
419.9
457.2
642.0
682.5
737.9
832.9
1,005.5
1,036.8
1,148.5
1,166.9
Revenue % Chg.
530.4%
8.9%
40.4%
6.3%
8.1%
12.9%
20.7%
3.1%
10.8%
10.1%
Cost of Revenue
203.6
228.7
383.6
404.9
444.4
520.9
628.1
654.2
729.8
740.3
Gross Profit
216.3
228.6
258.4
277.5
293.6
312.0
377.5
382.6
418.8
426.6
Gross Profit Margin
51.5%
50.0%
40.3%
40.7%
39.8%
37.5%
37.5%
36.9%
36.5%
36.6%
R&D Expenses
33.1
44.6
51.8
50.2
59.4
76.1
113.2
126.0
136.1
135.4
Selling, General, & Admin Expenses
69.3
73.0
78.2
80.1
90.4
76.2
70.5
79.3
89.9
93.4
Other Expenses
72.4
78.1
81.1
87.2
85.2
102.1
98.1
104.2
108.0
108.0
Operating Income
41.6
33.0
47.3
60.0
58.4
57.5
95.6
73.1
84.8
89.8
Operating Income Margin
9.9%
7.2%
7.4%
8.8%
7.9%
6.9%
9.5%
7.1%
7.4%
7.7%
Total Other Income/Expenses Net
-4.2
-21.3
-3.4
-2.4
-5.7
-2.1
-1.6
-10.9
-9.8
-9.0
Income Before Tax
37.4
11.7
43.8
57.6
52.7
55.4
94.0
62.2
75.0
80.8
Income Before Tax Margin
8.9%
2.6%
6.8%
8.4%
7.1%
6.7%
9.4%
6.0%
6.5%
6.9%
Income Tax Expense
10.3
16.9
12.2
16.1
20.6
14.5
24.3
29.5
13.3
4.7
Net Income
27.1
-5.2
31.6
41.5
32.7
41.6
70.7
33.0
62.5
76.7
Net Income Margin
6.5%
-1.1%
4.9%
6.1%
4.4%
5.0%
7.0%
3.2%
5.4%
6.6%
Weighted Avg. Shares Out
11.4
11.4
11.4
11.4
10.8
12.5
12.5
12.4
104.9
17.0
EPS
2.4
-0.5
2.8
3.6
3.0
3.3
5.6
2.7
0.6
5.8
EPS % Chg.
695.3%
—
—
31.4%
-16.9%
9.9%
70.2%
-53.0%
-77.5%
98.2%
Weighted Avg. Shares Out Dil
11.4
11.4
11.4
11.4
10.8
12.5
12.5
12.4
107.5
17.0
EPS Diluted
2.4
-0.5
2.8
3.6
3.0
3.3
5.6
2.7
0.6
5.8
Interest Income
0.7
0.5
0.1
0.5
0.5
0.7
1.0
0.6
1.7
2.2
Interest Expense
4.1
3.4
3.2
2.7
2.1
2.4
3.0
3.1
5.3
5.9
EBIT
34.0
8.8
40.7
55.3
51.1
53.7
92.0
59.6
71.3
77.1
EBIT Margin
8.1%
1.9%
6.3%
8.1%
6.9%
6.4%
9.2%
5.8%
6.2%
6.6%
Depreciation & Amortization
15.9
17.5
18.5
17.0
16.4
20.0
20.5
14.0
26.9
28.9
EBITDA
49.9
26.3
59.2
72.3
67.5
73.7
112.5
73.7
98.3
106.0
EBITDA Margin
11.9%
5.8%
9.2%
10.6%
9.1%
8.8%
11.2%
7.1%
8.6%
9.1%